ACYW135 meningococcal polysaccharide conjugate vaccine (CRM197 vector) of CANSINOBIO Co., Ltd.-Manhaixin ®(hereinafter referred to as: tetravalent meningococcal conjugate vaccine), the first batch of products obtained the "Biological products batch issuance Certificate" issued by the State Drug Administration, and officially listed on the domestic market. Manhaixin ®is the first ACYW135 group meningococcal conjugate vaccine in China, which fills the gap of lack of high-end vaccine products in this field. The successful launch of this product will bring more comprehensive and high-quality protection to Chinese children.
康希诺生物ACYW135群脑膜炎球菌多糖结合疫苗曼海欣®首批产品获得批签发
The first batch of CANSINOBIO ACYW135 meningococcal polysaccharide conjugate vaccine Manhaixin ®was issued in batch.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.